Canada markets close in 57 minutes

Annovis Bio, Inc. (ANVS)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
5.15-0.30 (-5.53%)
As of 03:03PM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
17,823
38,791
16,516
8,479
3,054
Selling General and Administrative
10,440
6,244
8,996
6,058
3,586
Total Operating Expenses
28,262
45,035
25,511
14,500
5,483
Operating Income or Loss
-28,262
-45,035
-25,511
-14,500
-5,483
Total Other Income/Expenses Net
-11,837
-11,837
-
-
-26.5
Income Before Tax
-28,148
-56,204
-25,329
-14,487
-5,462
Income from Continuing Operations
-28,148
-56,204
-25,329
-14,487
-5,462
Net Income
-28,148
-56,204
-25,329
-14,487
-5,462
Net Income available to common shareholders
-28,148
-56,204
-25,329
-14,487
-5,462
Basic EPS
-4.84
-
-3.10
-1.90
-0.87
Diluted EPS
-4.84
-
-3.10
-1.90
-0.87
Basic Average Shares
8,583
-
8,162
7,626
6,309
Diluted Average Shares
8,583
-
8,162
7,626
6,309